ReviewBlood and lymphatic cancer : targets and therapy2019

The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma.

Catherine Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.